-
1.
公开(公告)号:US5559111A
公开(公告)日:1996-09-24
申请号:US416242
申请日:1995-04-04
申请人: Richard G oschke , J urgen K. Maibaum , Walter Schilling , Stefan Stutz , Pascal Rigollier , Yasuchika Yamaguchi , Nissim C. Cohen , Peter Herold
发明人: Richard G oschke , J urgen K. Maibaum , Walter Schilling , Stefan Stutz , Pascal Rigollier , Yasuchika Yamaguchi , Nissim C. Cohen , Peter Herold
IPC分类号: C07D295/14 , A61K31/16 , A61K31/165 , A61K31/215 , A61K31/27 , A61K31/275 , A61K31/335 , A61K31/34 , A61K31/341 , A61K31/357 , A61K31/36 , A61K31/395 , A61K31/40 , A61K31/4015 , A61K31/41 , A61K31/415 , A61K31/4166 , A61K31/4245 , A61K31/44 , A61K31/445 , A61K31/4468 , A61K31/496 , A61K31/505 , A61K31/535 , A61K31/5375 , A61K31/5377 , A61K31/54 , A61P3/08 , A61P3/10 , A61P9/00 , A61P9/12 , A61P13/02 , A61P15/00 , A61P25/20 , A61P27/02 , A61P43/00 , C07C213/00 , C07C229/36 , C07C235/34 , C07C235/36 , C07C237/20 , C07C237/22 , C07C237/24 , C07C255/13 , C07C255/16 , C07C255/60 , C07C271/16 , C07C271/18 , C07C271/22 , C07C311/30 , C07C311/32 , C07C317/18 , C07C317/28 , C07C317/44 , C07C323/10 , C07C323/12 , C07D207/27 , C07D207/40 , C07D211/32 , C07D211/88 , C07D213/30 , C07D213/40 , C07D213/65 , C07D213/89 , C07D233/64 , C07D233/76 , C07D239/10 , C07D241/08 , C07D257/04 , C07D263/20 , C07D263/26 , C07D263/38 , C07D265/30 , C07D271/06 , C07D277/14 , C07D277/18 , C07D277/28 , C07D295/13 , C07D295/18 , C07D295/22 , C07D307/32 , C07D307/33 , C07D317/64 , C07D319/18 , C07D319/20 , C07D413/06 , C07D521/00 , C07F7/18 , C07D237/20 , C07D294/14
CPC分类号: C07D307/33 , C07C229/36 , C07C237/20 , C07C255/13 , C07C271/16 , C07C271/18 , C07C271/22 , C07D241/08
摘要: .delta.-Amino-.gamma.-hydroxy-.omega.-aryl-alkanoic acid amides of formula I ##STR1## and the salts thereof, have renin-inhibiting properties and can be used as antihypertensive medicinal active ingredients.
摘要翻译: 式I(Ⅰ)的α-氨基-γ-羟基-ω-芳基 - 链烷酸酰胺及其盐具有肾素抑制性质,可用作抗高血压药用活性成分。
-
2.
公开(公告)号:US5627182A
公开(公告)日:1997-05-06
申请号:US687878
申请日:1996-07-25
申请人: Richard G oschke , J urgen K. Maibaum , Walter Schilling , Stefan Stutz , Pascal Rigollier , Yasuchika Yamaguchi , Nissim C. Cohen , Peter Herold
发明人: Richard G oschke , J urgen K. Maibaum , Walter Schilling , Stefan Stutz , Pascal Rigollier , Yasuchika Yamaguchi , Nissim C. Cohen , Peter Herold
IPC分类号: C07D295/14 , A61K31/16 , A61K31/165 , A61K31/215 , A61K31/27 , A61K31/275 , A61K31/335 , A61K31/34 , A61K31/341 , A61K31/357 , A61K31/36 , A61K31/395 , A61K31/40 , A61K31/4015 , A61K31/41 , A61K31/415 , A61K31/4166 , A61K31/4245 , A61K31/44 , A61K31/445 , A61K31/4468 , A61K31/496 , A61K31/505 , A61K31/535 , A61K31/5375 , A61K31/5377 , A61K31/54 , A61P3/08 , A61P3/10 , A61P9/00 , A61P9/12 , A61P13/02 , A61P15/00 , A61P25/20 , A61P27/02 , A61P43/00 , C07C213/00 , C07C229/36 , C07C235/34 , C07C235/36 , C07C237/20 , C07C237/22 , C07C237/24 , C07C255/13 , C07C255/16 , C07C255/60 , C07C271/16 , C07C271/18 , C07C271/22 , C07C311/30 , C07C311/32 , C07C317/18 , C07C317/28 , C07C317/44 , C07C323/10 , C07C323/12 , C07D207/27 , C07D207/40 , C07D211/32 , C07D211/88 , C07D213/30 , C07D213/40 , C07D213/65 , C07D213/89 , C07D233/64 , C07D233/76 , C07D239/10 , C07D241/08 , C07D257/04 , C07D263/20 , C07D263/26 , C07D263/38 , C07D265/30 , C07D271/06 , C07D277/14 , C07D277/18 , C07D277/28 , C07D295/13 , C07D295/18 , C07D295/22 , C07D307/32 , C07D307/33 , C07D317/64 , C07D319/18 , C07D319/20 , C07D413/06 , C07D521/00 , C07F7/18 , C07D293/14
CPC分类号: C07D307/33 , C07C229/36 , C07C237/20 , C07C255/13 , C07C271/16 , C07C271/18 , C07C271/22 , C07D241/08
摘要: .delta.-Amino-.gamma.-hydroxy-.omega.-aryl-alkanoic acid amides of formula I ##STR1## and the salts thereof, have renin-inhibiting properties and can be used as antihypertensive medicinal active ingredients.
摘要翻译: 式I(Ⅰ)的α-氨基-γ-羟基-ω-芳基 - 链烷酸酰胺及其盐具有肾素抑制性质,可用作抗高血压药用活性成分。
-
公开(公告)号:US5606078A
公开(公告)日:1997-02-25
申请号:US416237
申请日:1995-04-04
IPC分类号: C07C229/36 , C07C231/02 , C07C237/20 , C07C255/13 , C07C271/16 , C07C271/18 , C07C271/22 , C07D241/08 , C07D263/26 , C07D295/13 , C07D307/33 , C07D413/06
CPC分类号: C07D307/33 , C07C229/36 , C07C231/02 , C07C237/20 , C07C255/13 , C07C271/16 , C07C271/18 , C07C271/22 , C07D241/08 , C07D263/26 , C07D295/13 , C07D413/06 , Y02P20/55
摘要: Compounds of formula I ##STR1## wherein R.sub.1 is free or esterified carboxy, hydroxymethyl or formyl,R.sub.2 and R.sub.4 are each independently of the other aliphatic, cycloaliphatic-aliphatic, araliphatic or heteroarylaliphatic radicals andR.sub.3 is azido, or amino that is aliphatically or araliphatically substituted and/or protected by an amino-protecting group,and the salts thereof, are valuable intermediates in the preparation of medicinal active ingredients, for example of compounds of formula II ##STR2## wherein R.sub.A is an aromatic or heteroaromatic radical,R.sub.2 and R.sub.4 are each independently of the other aliphatic, cycloaliphatic, cycloaliphaticaliphatic or araliphatic radicals,R.sub.3 is unsubstituted or N-mono- or N,N-di-lower alkylated or N-lower alkanoylated amino, andR.sub.B is an aliphatically, cycloaliphatically or heteroaromatically-aliphatically substituted amino group,and the salts thereof, which can be used, for example, as antihypertensives.
摘要翻译: 式I的化合物其中R 1是游离的或酯化的羧基,羟甲基或甲酰基,R 2和R 4各自独立地是其它脂族,脂环族 - 脂族,芳脂族或杂芳基脂族基,R 3是叠氮基或氨基, 通过氨基保护基团及其盐的脂质或芳香取代和/或保护是制备药物活性成分的有价值的中间体,例如式II化合物(IIb)(IIb) 其中RA是芳族或杂芳族基团,R 2和R 4各自独立地为其它脂族,脂环族,脂环族或芳脂族基团,R3是未取代的或N-单或N,N-二低级烷基化或N-低级烷酰基氨基 ,RB是脂肪,脂环或杂芳基 - 脂族取代的氨基及其盐,其可用作例如抗高血压药。
-
4.Aromatically substituted .omega.-amino-alkanoic acid amides and alkanoic acid diamides 失效
标题翻译: 芳基取代的ω-氨基 - 链烷酸酰胺和链烷酸二酰胺公开(公告)号:US5641778A
公开(公告)日:1997-06-24
申请号:US568332
申请日:1995-12-06
申请人: Jurgen Klaus Maibaum , Pascal Rigollier , Peter Herold , Nissim Claude Cohen , Richard Goschke , Stefan Stutz
发明人: Jurgen Klaus Maibaum , Pascal Rigollier , Peter Herold , Nissim Claude Cohen , Richard Goschke , Stefan Stutz
IPC分类号: C07D295/12 , A61K31/16 , A61K31/165 , A61K31/27 , A61K31/38 , A61K31/40 , A61K31/403 , A61K31/404 , A61K31/405 , A61K31/41 , A61K31/44 , A61K31/4427 , A61K31/443 , A61K31/445 , A61K31/4468 , A61K31/451 , A61K31/495 , A61K31/535 , A61K31/5375 , A61K31/5377 , A61K31/54 , A61K31/695 , A61P9/12 , C07C231/02 , C07C231/12 , C07C237/06 , C07C237/08 , C07C237/10 , C07C237/12 , C07C237/22 , C07C237/36 , C07C237/42 , C07D207/00 , C07D207/06 , C07D209/04 , C07D209/08 , C07D209/42 , C07D211/00 , C07D211/32 , C07D211/46 , C07D213/02 , C07D213/81 , C07D213/82 , C07D241/00 , C07D241/04 , C07D257/04 , C07D263/04 , C07D263/14 , C07D265/28 , C07D279/12 , C07D295/092 , C07D295/15 , C07D295/18 , C07D295/185 , C07D307/32 , C07D307/33 , C07D401/04 , C07D401/12 , C07D405/12 , C07D407/12 , C07D413/12 , C07D413/14 , C07D521/00 , C07F7/10 , C07D295/145
CPC分类号: C07D213/81 , C07C237/08 , C07C237/22 , C07C237/36 , C07C237/42 , C07D209/42 , C07D211/46 , C07D213/82 , C07D257/04 , C07D263/04 , C07D295/088 , C07D295/15 , C07D295/185 , C07D307/32 , C07D401/04 , C07D405/12 , C07D413/12 , C07D413/14
摘要: Compounds of formula I ##STR1## wherein R.sub.1 is a 2-R.sub.A -3-R.sub.B -phenyl radical, a 2-R.sub.A -4-R.sub.C -phenyl radical, a 2-R.sub.A -pyridin-3-yl radical, a 3-R.sub.A -pyridin-2-yl radical or a 1-R.sub.D -indol-3-yl radical, wherein one of the radicals R.sub.A and R.sub.B is an aliphatic or heterocycloaliphatic-aliphatic radical or free or aliphatically, araliphatically or heteroaraliphatically etherified hydroxy and the other is hydrogen, an aliphatic radical or free or esterified or amidated carboxy, R.sub.C is hydrogen, an aliphatic radical, free or aliphatically, araliphatically, heteroaraliphatically or heteroarylaliphatically etherified hydroxy or an unsubstituted or heteroaliphatically substituted amino group, and R.sub.D is an aliphatic, araliphatic or heteroaliphatic radical, one of the radicals X.sub.1 and X.sub.2 is carbonyl and the other is methylene, R.sub.2 is an aliphatic radical, R.sub.3 is unsubstituted or aliphatically substituted amino, R.sub.4 is an aliphatic or araliphatic radical, and R.sub.5 is an aliphatic or cycloaliphatic-aliphatic radical or an optionally hydrogenated and/or oxo-substituted heteroaryl radical or an optionally hydrogenated and/or oxo-substituted heteroaryl or heteroaliphatyl radical bonded via a carbon atom, and the salts thereof, have renin-inhibiting properties and can be used as antihypertensive active ingredients of medicaments.
摘要翻译: 式I的化合物其中R1是2-RA-3-RB-苯基,2-RA-4-RC-苯基,2-RA-吡啶-3-基, 3-RA-吡啶-2-基或1-RD-吲哚-3-基,其中基团RA和RB之一是脂族或杂环脂族 - 脂族基或自由或脂族,芳烃或杂芳烃醚化的羟基和 另一个是氢,脂族基团或游离的或酯化的或酰胺化的羧基,RC是氢,脂族基团,游离或脂族的,芳香烃,杂芳烃或杂芳基醚化的羟基或未取代的或杂芳基取代的氨基,RD是脂族, 芳基脂族或杂脂族基团,基团X 1和X 2之一是羰基,另一个是亚甲基,R 2是脂族基团,R 3是未取代的或脂族取代的氨基,R 4是脂族或芳脂族基团,R 5是脂族或脂环族基团, 脂肪族基 任选氢化和/或氧取代的杂芳基或任选氢化和/或氧取代的通过碳原子键合的杂芳基或杂芳基与其盐具有肾素抑制性质,并且可以用作抗高血压活性成分 的药物。
-
5.
公开(公告)号:US5646143A
公开(公告)日:1997-07-08
申请号:US687277
申请日:1996-07-25
申请人: Richard Goschke , Jurgen Klaus Maibaum , Walter Schilling , Stefan Stutz , Pascal Rigollier , Yasuchika Yamaguchi , Nissim Claude Cohen , Peter Herold
发明人: Richard Goschke , Jurgen Klaus Maibaum , Walter Schilling , Stefan Stutz , Pascal Rigollier , Yasuchika Yamaguchi , Nissim Claude Cohen , Peter Herold
IPC分类号: C07D295/14 , A61K31/16 , A61K31/165 , A61K31/215 , A61K31/27 , A61K31/275 , A61K31/335 , A61K31/34 , A61K31/341 , A61K31/357 , A61K31/36 , A61K31/395 , A61K31/40 , A61K31/4015 , A61K31/41 , A61K31/415 , A61K31/4166 , A61K31/4245 , A61K31/44 , A61K31/445 , A61K31/4468 , A61K31/496 , A61K31/505 , A61K31/535 , A61K31/5375 , A61K31/5377 , A61K31/54 , A61P3/08 , A61P3/10 , A61P9/00 , A61P9/12 , A61P13/02 , A61P15/00 , A61P25/20 , A61P27/02 , A61P43/00 , C07C213/00 , C07C229/36 , C07C235/34 , C07C235/36 , C07C237/20 , C07C237/22 , C07C237/24 , C07C255/13 , C07C255/16 , C07C255/60 , C07C271/16 , C07C271/18 , C07C271/22 , C07C311/30 , C07C311/32 , C07C317/18 , C07C317/28 , C07C317/44 , C07C323/10 , C07C323/12 , C07D207/27 , C07D207/40 , C07D211/32 , C07D211/88 , C07D213/30 , C07D213/40 , C07D213/65 , C07D213/89 , C07D233/64 , C07D233/76 , C07D239/10 , C07D241/08 , C07D257/04 , C07D263/20 , C07D263/26 , C07D263/38 , C07D265/30 , C07D271/06 , C07D277/14 , C07D277/18 , C07D277/28 , C07D295/13 , C07D295/18 , C07D295/22 , C07D307/32 , C07D307/33 , C07D317/64 , C07D319/18 , C07D319/20 , C07D413/06 , C07D521/00 , C07F7/18 , C07D413/12
CPC分类号: C07D307/33 , C07C229/36 , C07C237/20 , C07C255/13 , C07C271/16 , C07C271/18 , C07C271/22 , C07D241/08
摘要: .delta.-Amino-.gamma.-hydroxy-.omega.-aryl-alkanoic acid amides of formula I ##STR1##
摘要翻译: (I)的△-Amin-γ-羟基-ω-芳基 - 链烷酸酰胺
-
公开(公告)号:US5705658A
公开(公告)日:1998-01-06
申请号:US800671
申请日:1997-02-14
申请人: Richard Goschke , Jurgen Klaus Maibaum , Walter Schilling , Stefan Stutz , Pascal Rigollier , Yasuchika Yamaguchi , Nissim Claude Cohen , Peter Herold
发明人: Richard Goschke , Jurgen Klaus Maibaum , Walter Schilling , Stefan Stutz , Pascal Rigollier , Yasuchika Yamaguchi , Nissim Claude Cohen , Peter Herold
IPC分类号: C07D295/14 , A61K31/16 , A61K31/165 , A61K31/215 , A61K31/27 , A61K31/275 , A61K31/335 , A61K31/34 , A61K31/341 , A61K31/357 , A61K31/36 , A61K31/395 , A61K31/40 , A61K31/4015 , A61K31/41 , A61K31/415 , A61K31/4166 , A61K31/4245 , A61K31/44 , A61K31/445 , A61K31/4468 , A61K31/496 , A61K31/505 , A61K31/535 , A61K31/5375 , A61K31/5377 , A61K31/54 , A61P3/08 , A61P3/10 , A61P9/00 , A61P9/12 , A61P13/02 , A61P15/00 , A61P25/20 , A61P27/02 , A61P43/00 , C07C213/00 , C07C229/36 , C07C235/34 , C07C235/36 , C07C237/20 , C07C237/22 , C07C237/24 , C07C255/13 , C07C255/16 , C07C255/60 , C07C271/16 , C07C271/18 , C07C271/22 , C07C311/30 , C07C311/32 , C07C317/18 , C07C317/28 , C07C317/44 , C07C323/10 , C07C323/12 , C07D207/27 , C07D207/40 , C07D211/32 , C07D211/88 , C07D213/30 , C07D213/40 , C07D213/65 , C07D213/89 , C07D233/64 , C07D233/76 , C07D239/10 , C07D241/08 , C07D257/04 , C07D263/20 , C07D263/26 , C07D263/38 , C07D265/30 , C07D271/06 , C07D277/14 , C07D277/18 , C07D277/28 , C07D295/13 , C07D295/18 , C07D295/22 , C07D307/32 , C07D307/33 , C07D317/64 , C07D319/18 , C07D319/20 , C07D413/06 , C07D521/00 , C07F7/18
CPC分类号: C07D307/33 , C07C229/36 , C07C237/20 , C07C255/13 , C07C271/16 , C07C271/18 , C07C271/22 , C07D241/08
摘要: .delta.-Amino-.gamma.-hydroxy-.omega.-aryl-alkanoic acid amides of formula I ##STR1## and the salts thereof, have renin-inhibiting properties and can be used as antihypertensive medicinal active ingredients.
摘要翻译: 式I(Ⅰ)的α-氨基-γ-羟基-ω-芳基 - 链烷酸酰胺及其盐具有肾素抑制性质,可用作抗高血压药用活性成分。
-
公开(公告)号:US5654445A
公开(公告)日:1997-08-05
申请号:US674555
申请日:1996-07-02
申请人: Richard Goschke , Jurgen Klaus Maibaum , Walter Schilling , Stefan Stutz , Pascal Rigollier , Yasuchika Yamaguchi , Nissim Claude Cohen , Peter Herold
发明人: Richard Goschke , Jurgen Klaus Maibaum , Walter Schilling , Stefan Stutz , Pascal Rigollier , Yasuchika Yamaguchi , Nissim Claude Cohen , Peter Herold
IPC分类号: C07D295/14 , A61K31/16 , A61K31/165 , A61K31/215 , A61K31/27 , A61K31/275 , A61K31/335 , A61K31/34 , A61K31/341 , A61K31/357 , A61K31/36 , A61K31/395 , A61K31/40 , A61K31/4015 , A61K31/41 , A61K31/415 , A61K31/4166 , A61K31/4245 , A61K31/44 , A61K31/445 , A61K31/4468 , A61K31/496 , A61K31/505 , A61K31/535 , A61K31/5375 , A61K31/5377 , A61K31/54 , A61P3/08 , A61P3/10 , A61P9/00 , A61P9/12 , A61P13/02 , A61P15/00 , A61P25/20 , A61P27/02 , A61P43/00 , C07C213/00 , C07C229/36 , C07C235/34 , C07C235/36 , C07C237/20 , C07C237/22 , C07C237/24 , C07C255/13 , C07C255/16 , C07C255/60 , C07C271/16 , C07C271/18 , C07C271/22 , C07C311/30 , C07C311/32 , C07C317/18 , C07C317/28 , C07C317/44 , C07C323/10 , C07C323/12 , C07D207/27 , C07D207/40 , C07D211/32 , C07D211/88 , C07D213/30 , C07D213/40 , C07D213/65 , C07D213/89 , C07D233/64 , C07D233/76 , C07D239/10 , C07D241/08 , C07D257/04 , C07D263/20 , C07D263/26 , C07D263/38 , C07D265/30 , C07D271/06 , C07D277/14 , C07D277/18 , C07D277/28 , C07D295/13 , C07D295/18 , C07D295/22 , C07D307/32 , C07D307/33 , C07D317/64 , C07D319/18 , C07D319/20 , C07D413/06 , C07D521/00 , C07F7/18
CPC分类号: C07D307/33 , C07C229/36 , C07C237/20 , C07C255/13 , C07C271/16 , C07C271/18 , C07C271/22 , C07D241/08
摘要: .delta.-Amino-.gamma.-hydroxy-.omega.-aryl-alkanoic acid amides of formula I ##STR1## and the salts thereof, have renin-inhibiting properties and can be used as antihypertensive medicinal active ingredients.
摘要翻译: 式I(Ⅰ)的α-氨基-γ-羟基-ω-芳基 - 链烷酸酰胺及其盐具有肾素抑制性质,可用作抗高血压药用活性成分。
-
公开(公告)号:US08613914B2
公开(公告)日:2013-12-24
申请号:US13614902
申请日:2012-09-13
IPC分类号: A61K45/00
CPC分类号: C07K7/06 , A61K31/403 , A61K31/4439 , A61K38/06 , A61K38/07 , A61K38/08 , A61K45/06 , C07D209/96 , C07D401/12 , C07D401/14 , C07D403/12 , C07D403/14 , C07D405/14 , C07D417/14 , C07K5/06165 , C07K5/08 , C07K5/0808 , C07K5/0812 , C07K5/10 , C07K5/101 , C07K5/1016
摘要: The present application describes organic compounds that are useful for the treatment, prevention and/or amelioration of human diseases.
摘要翻译: 本申请描述了可用于治疗,预防和/或改善人类疾病的有机化合物。
-
公开(公告)号:US20120258954A1
公开(公告)日:2012-10-11
申请号:US13481983
申请日:2012-05-29
申请人: Claus Ehrhardt , Leslie Wighton McQuire , Pascal Rigollier , Olivier Rogel , Michael Shultz , Ruben Alberto Tommasi
发明人: Claus Ehrhardt , Leslie Wighton McQuire , Pascal Rigollier , Olivier Rogel , Michael Shultz , Ruben Alberto Tommasi
IPC分类号: A61K31/18 , A61K31/402 , A61K31/451 , A61K31/495 , A61K31/40 , A61K31/381 , A61K31/437 , A61K31/55 , A61K31/404 , A61K31/4439 , A61K31/416 , A61P11/06 , A61P11/00 , A61P19/02 , A61P9/10 , A61P35/00 , A61P35/04 , A61P9/04 , A61P25/28 , A61P25/00 , A61K31/4402
CPC分类号: C07D333/22 , A61K31/18 , A61K31/381 , A61K31/402 , A61K31/416 , A61K31/437 , A61K31/4402 , A61K31/4409 , A61K31/451 , A61K31/495 , A61K31/5375 , A61K31/55 , A61K45/06 , C07C311/16 , C07C311/29 , C07C311/39 , C07C311/46 , C07C317/24 , C07C323/67 , C07C2601/02 , C07C2601/08 , C07C2601/14 , C07C2602/08 , C07D207/20 , C07D207/30 , C07D207/333 , C07D209/08 , C07D209/10 , C07D209/12 , C07D209/14 , C07D209/80 , C07D209/82 , C07D211/06 , C07D211/14 , C07D211/24 , C07D213/40 , C07D213/50 , C07D213/61 , C07D221/16 , C07D223/04 , C07D231/56 , C07D235/06 , C07D235/08 , C07D241/04 , C07D265/30 , C07D295/112 , C07D295/116 , C07D295/192 , C07D333/18 , C07D401/04 , C07D403/04 , C07D409/04 , C07D413/04 , C07D471/04 , C07D487/04
摘要: The present invention provides a compound of formula (I): said compound is inhibitor of MMP-2, and/or MMP-8, and/or MMP-9, and/or MMP-12 and/or MMP-13, and thus can be employed for the treatment of a disorder or disease characterized by abnormal activity of MMP-2, and/or MMP-8, and/or MMP-9, and/or MMP-12 and/or MMP-13. Accordingly, the compound of formula (I) can be used in treatment of disorders or diseases mediated by MMP-2, and/or MMP-8, and/or MMP-9, and/or MMP-12, and/or MMP-13. Finally, the present invention also provides a pharmaceutical composition.
摘要翻译: 本发明提供式(I)化合物:所述化合物是MMP-2和/或MMP-8和/或MMP-9和/或MMP-12和/或MMP-13的抑制剂,因此 可以用于治疗以MMP-2,/或MMP-8和/或MMP-9,和/或MMP-12和/或MMP-13异常活性为特征的疾病或疾病。 因此,式(I)化合物可用于治疗由MMP-2和/或MMP-8和/或MMP-9和/或MMP-12和/或MMP- 13。 最后,本发明还提供药物组合物。
-
公开(公告)号:US20140357551A1
公开(公告)日:2014-12-04
申请号:US14462406
申请日:2014-08-18
CPC分类号: C07K7/06 , A61K31/403 , A61K31/4439 , A61K38/06 , A61K38/07 , A61K38/08 , A61K45/06 , C07D209/96 , C07D401/12 , C07D401/14 , C07D403/12 , C07D403/14 , C07D405/14 , C07D417/14 , C07K5/06165 , C07K5/08 , C07K5/0808 , C07K5/0812 , C07K5/10 , C07K5/101 , C07K5/1016
摘要: The present application describes organic compounds of Formula (II) that are useful for the treatment, prevention and/or amelioration of human diseases.
摘要翻译: 本申请描述了可用于治疗,预防和/或改善人类疾病的式(II)的有机化合物。
-
-
-
-
-
-
-
-
-